INGENIOUS TARGETING LABORATORY INC.
Genetically humanized mouse models for SARS-CoV-2 research and drug/vaccine testing
- Sector
- Biotech
- Headquarters
- Ronkonkoma, NY
- Total capital
- $6.9M
- Federal grants
- $5.2M
- 11 awards · 2018–2024
- Rank in peer group#1 of 26
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.7M
- 60 awards · Health and Human S, Veterans Affairs, Defense
- Rank in Biotech#148 of 4373
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Niddk: Supplies - This Firm Fixed Price Purchase Order Is Awarded For Custom Conditional Knockin Mouse To Ingenious Targeting Lab INC:1106221 - Severable Invoicing Performed In Three Or Four Payments Gene Id: ENSEMBL:ENSMUSG00000000394$22K
- Federal contractHealth and Human S · FY26 Udo Initiative - Custom Conditional Gpnmb Cdna Cassette Knockin Mouse Model$25K
- Federal grantHealth and Human S · Phase II · Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies$996K
- Federal contractVeterans Affairs · Live Mice$18K
- Federal contractHealth and Human S · Knockin Mouse Es Cell Line$14K
- Federal grantHealth and Human S · Phase II · Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies$995K
- Federal contractHealth and Human S · Custom Reporter Cdna Replacement Knockin Mouse - Research Animal$22K
Show 62 earlier federal awards
- Federal grantHealth and Human S · Phase II · Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies$999K
- Federal grantHealth and Human S · Phase I · Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19$293K
- Federal contractVeterans Affairs · Knockout Mouse$23K
- Federal grantHealth and Human S · Phase I · Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19$590K
- Federal grantHealth and Human S · Phase I · Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19$297K
- Federal grantHealth and Human S · Phase I · Business Potential of a Novel Small Animal Model and its Single-Chain Antibodies$55K
- Federal contractHealth and Human S · Generation Of Custom Conditional CERS4 Knockout Mouse Model$23K
- Federal contractHealth and Human S · Nichd Lab Services: Sample Production$25K
- Federal contractVeterans Affairs · Vector Services$18K
- Federal contractHealth and Human S · Ingenious Targeting Lab INC:1106221 [19-012398]$12K
- Federal contractHealth and Human S · Delivery Of A 6 Week Old Breeding Pair Of NEU3 Floxed Mice$23K
- Federal grantHealth and Human S · Phase I · A Novel Small Animal Model as a Source of Therapy-Bound Single-Chain Antibody Products$258K
- Federal grantHealth and Human S · Phase I · Genetic Modification of the Rabbit for Development of Single Chain Antibodies$225K
- Federal grantHealth and Human S · Phase I · Genetic Modification of the Rabbit for Development of Single Chain Antibodies$225K
- Federal contractHealth and Human S · Generation Of Vectors$13K
- Federal grantHealth and Human S · Phase I · A Novel Small Animal Model as a Source of Therapy-Bound Single-Chain Antibody Products$280K
- Federal contractHealth and Human S · Igf::ot::igf Other Function - Transgenic CB-2 Reporter Mouse - Ingenious Targeting Lab INC:1106221 [18-001542]$11K
- Federal contractHealth and Human S · Igf::ot::igf Other Function - Gene Targeted Es Cell Clones - Ingenious Targeting Lab INC:1106221 [17-006192]$24K
- Federal contractHealth and Human S · Ingenious Targeting Lab - Transgenic Mouse Model$45K
- Federal contractHealth and Human S · Igf::ot::igf - Ingenious Targeting Lab INC:1106221 [17-003897]$20K
- Federal contractHealth and Human S · Igf::ot::igf - Ingenious Targeting Lab INC:1106221 [16-009622]$29K
- Federal contractHealth and Human S · Igf::ot::igf$115K
- Federal contractHealth and Human S · Igf::ot::igf - Pots: 15-008002 Cloning And Construction Of Targeting Vector (cloning And Construction Of Targeting Vectorconditional Targeting Of ~3KB Or Less) Duration: 2-3 Months$8K
- Federal contractHealth and Human S · Igf::ot::igf - Milestone I - Cloning And Construction Of Targeting Vector Deliverables: Targeting Vector$43K
- Federal contractVeterans Affairs · The Procurement Of Genetically Modified Research Models Designed To Examine The Molecular Mechanisms Responsible For The Onset And Persistence Of Small Fiber Neuropathy (sfn). Since Many Veterans Suffer From Sfn, These Studies Are Critically Important To The Mission Of The Va.igf::ot::igf$61K
- Federal contractHealth and Human S · Igf::ot::igf$35K
- Federal contractHealth and Human S · Igf::ot::igf Laboratory Testing Services With Ingenious Targeting Laboratory. Bill: $9500.00 Clonging And Constructing = Total $34,745.00. Cus: Dr. Lothar Henninghausen 301.496.2716. Pa: Liz Scott 2406889072. POTS14-007200.$34K
- Federal contractHealth and Human S · Igf::ot::igf - Pots # 14-008984, Ingenious Targeting, Cloning And Construction Of Targeting Vector And Client-provided Tagged CAS9 Cdna, Deliverables: Targeting Vector Time Line: 1-2 Months$10K
- Federal contractHealth and Human S · Igf::ot::igf Laboratory Testing Services With Ingenious Targeting Laboratory. Bill: $7500.00 Clonging And Constructing = Total $29,845.00. Cus: Dr. Gertraud Robinson 301.496.4005. Pa: Liz Scott 2406889072. POTS14-007237.$30K
- Federal contractHealth and Human S · Igf::ot::igf Cloning And Construction Of Targeting Vector$8K
- Federal contractHealth and Human S · Igf::ot::igf Lab Services Performed By Ingenious Targeting Laboratory. Bill: 4 Pymts Totalling $28,595.00. Pop: 10 Months. Cus: Rick Proia 4964391. Pa: Liz Scott 2406889072. POTS14-003590.$29K
- Federal contractHealth and Human S · Igf::ot::igf TAS::75 0884::TAS. Mouse Model Study.$34K
- Federal contractHealth and Human S · Igf::ct::igf Ingenious Targeting Lab INC:1106221 [14-002269]$37K
- Federal contractHealth and Human S · Igf::cl::igf Cloning And Constructin Of Trageting Vector 1DELIVERABLES: Targeting Vector.$28K
- Federal contractHealth and Human S · Ingenious Targeting Lab INC:1106221 [13-011435]$8K
- Federal contractHealth and Human S · ROSA26 Knock-in Mice$31K
- Federal contractHealth and Human S · Ingenious Targeting Lab INC:1106221 [13-006569]$12K
- Federal contractHealth and Human S · Igf::cl,ct::igf Cloning And Construction Of Targeting Vector: Milestone I$50K
- Federal contractHealth and Human S · Tas:: 75 0884:: Tas Pots # 12-009421 Quote # Q_208009[2] Cloning&construction Of Targeting Vector$48K
- Federal contractHealth and Human S · Igf::ot::igf Cloning And Construction Of Targeting Vector --- The Shared Cost Of This Project With A Collaborating Lab (roger Nicoll''s Lab At The University Of California San Francisco, -- Catalog # : Milestone 1A -- Total Of $25,847.50 Shared$13K
- Federal contractHealth and Human S · Generation Of One Conditional Ko Mouse Model, Gene Of Interest: ORMDL3. Milestone 1: Cloning And Construction Of Targeting Vector. Requester: Dr. Richard Proia, Bldg 10, Rm 9D06. Pa: Emily Wertz, 301-594-3947. Pots 12-007519.$51K
- Federal contractHealth and Human S · Cloning And Construction Of Targeting Vector (as Listed In Quote 120406 Kai Ge)$13K
- Federal contractHealth and Human S · Ingenious Targeting Lab INC:1106221 Gene Targeted Mouse Model Production$51K
- Federal contractHealth and Human S · Electroporation Of Niddk Provided Hybrid Es Cells;pcr Screening;southern Blot Confirmation Of Clones. Invoiced After Milestone Iib Completed.$6K
- Federal contractHealth and Human S · Option B: Milestones For Creating One Mouse Knockin Based On Customer's Targeting Construct Itl Will Perform Screening). Customer: Mari Kono, Bldg 10, Rm 9D08. Pa: Emily Wertz, 301-594-3947. Pots 11-007090.$34K
- Federal contractVeterans Affairs · Design&production Of Mice Knockout Model With ANK3 Gene.$69K
- Federal contractDefense · Generation Of A Custom Mouse Model To Study Longitudinal Effects Of NEUROG1 Deletion In Postnatal Mice.$51K
- Federal contractVeterans Affairs · Research$11K
- Federal contractVeterans Affairs · Creation Of Custom Gene Knockout Mice$51K
- Federal contractHealth and Human S · TAS::75 0884::TAS Production Of Knockout Mouse From Existing Es Cell Line. TAS::75 0884::TAS$10K
- Federal contractVeterans Affairs · Gene Targeting Services$37K
- Federal contractHealth and Human S · TAS::75 0884::TAS Ingenious Targeting Laboratory, Inc. [10-005364]$49K
- Federal contractHealth and Human S · ITL-065 Design/creation Of Targeting Vector Cloning Mouse$56K
- Federal contractHealth and Human S · Electroporation Of Es Cells-for Robert Craigie$11K
- Federal contractHealth and Human S · Creating Conditional Knockout Mouse Based On Targeting Vector And Es Cells Generated, Including Clone Screening, Blastocyst Injection, Mouse Breeding, And Shipping. Requester: Ewa Turner, Bldg 10, Rm 9D08. Pa: Emily Wertz, 301-594-3947.$25K
- Federal contractHealth and Human S · Construction Of Conditional Targeting Vector & Cloning Of Mouse Genomic Dna$45K
- Federal contractHealth and Human S · Design/creation Of Targeting Vector$24K
- Federal contractVeterans Affairs · Mouse Knockin Project:$16K
- Federal contractHealth and Human S · TAS::75 0943::TAS 0000HCCC-2008-57375 - Ingenious Targeting Laboratory, Inc.$9K
- Federal contractHealth and Human S · ITL-550 Housing And Breeding Of Chimeras And F1 HETEROZYGOTES.ITL666 Shipping$4K
- Federal contractHealth and Human S · Custom Conditional Gene Knockout From Itl-reference QUW70164$48K
- Federal contractHealth and Human S · Small Procurement$6K
Federal awards are summed by year (69 awards); hover a bar for the split. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
2 records have no date or no amount, so they aren’t placed on the timeline.
Standing among 26 peers
Line = medianBiotech · Instrument
- Federal grants#1 · top 4%
- Linked publications#3 · top 12%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 8- PendingModified Mice That Produce Heavy Chain Only AntibodiesUSPTOApplication 17823506
- PendingModified Mice That Produce Heavy Chain Only AntibodiesUSPTOApplication 63238703
- PendingKnockout Mice Derived From Site Specific RecombinaseUSPTOApplication PCTUS2014048122
Show all 8 patent records
- Modified Mice That Produce Heavy Chain Only AntibodiesMar 2, 2023 · Application 17823506Pending
- Modified Mice That Produce Heavy Chain Only AntibodiesApplication 63238703Pending
- Knockout Mice Derived From Site Specific RecombinaseApplication PCTUS2014048122Pending
- System And Methods Of Making Custom FootwearApplication PCTUS2007086014Pending
- System For 3D Monitoring And Analysis Of Motion Behavior Of TargetsApplication PCTUS2006026602Pending
- Gene Targeting In Rat Stem Cells And Non_stem Cells Using Isogenic And Non-isogenic Dna ConstructsApplication PCTUS2005036742Pending
- Industry Standard Multi-well Plates With Increased Capacity And Efficiency Per WellApplication PCTUS2005017829Pending
- Genetic Modification Of C57 MiceApplication PCTUS2005003027Pending
Recent research by its founders
- Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity20260 cites
- Tariffs, transportation, and profits in cross-border e-commerce: A dual-channel supply chain decision-making strategy20253 cites
- The Cytotoxic Potential of Humanized γδ T Cells Against Human Cancer Cell Lines in In Vitro20252 cites
Related companies, and why
- LUCERNA INCSimilar federal contract value in Biotech · $1.8M in contracts
- Blaze Bioscience, Inc.Similar federal contract value in Biotech · $1.7M in contracts
- ADJUVANCE TECHNOLOGIES INC.Similar federal contract value in Biotech · $1.7M in contracts
- SCRIBE BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.7M in contracts
- Strand Therapeutics Inc.Similar federal contract value in Biotech · $1.6M in contracts
- MAKSCIENTIFICSimilar federal contract value in Biotech · $1.6M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .